FDA
-
-
-
-
-
-
-
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
-
-
-
-
-
-
-
Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments
-
-
-
-
-
-
-
Galderma Launches EPSOLAY® Cream, a Medical Advance to Treat Bumps and Blemishes of Rosacea
-
-
-
-
-
-
-
Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA
-
-
-
-
-
-
-
Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million
-
-
-
-
-
-
-
Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021
-
-
-
-
-
-
-
Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update
-
251,731 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All